Review



tonsil ffpe block  (AMS Biotechnology)


Bioz Verified Symbol AMS Biotechnology is a verified supplier
Bioz Manufacturer Symbol AMS Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    AMS Biotechnology tonsil ffpe block
    Tonsil Ffpe Block, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tonsil ffpe block/product/AMS Biotechnology
    Average 94 stars, based on 3 article reviews
    tonsil ffpe block - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    tonsil ffpe block  (AMS Biotechnology)
    94
    AMS Biotechnology tonsil ffpe block
    Tonsil Ffpe Block, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tonsil ffpe block/product/AMS Biotechnology
    Average 94 stars, based on 1 article reviews
    tonsil ffpe block - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    tonsil tissue  (Marburg GmbH)
    90
    Marburg GmbH tonsil tissue
    Tonsil Tissue, supplied by Marburg GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tonsil tissue/product/Marburg GmbH
    Average 90 stars, based on 1 article reviews
    tonsil tissue - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    tonsil tissues  (AMS Biotechnology)
    94
    AMS Biotechnology tonsil tissues
    Tonsil Tissues, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tonsil tissues/product/AMS Biotechnology
    Average 94 stars, based on 1 article reviews
    tonsil tissues - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    ffpe tissues  (AMS Biotechnology)
    94
    AMS Biotechnology ffpe tissues
    (A) Overview schematic of the PASTA workflow. HRP recruitment including in situ hybridization, unconjugated antibodies, and proximity ligation assays enables tyramine radical formation. These radicals deposit oligos onto nearby proteins in the cells and tissues through covalent binding to tyrosine residues, creating stable protein-oligonucleotide conjugates that resist degradation and enable serial amplification. (B) Concentration-dependent signal amplification of CD3 and Iba1 in <t>FFPE</t> <t>tissues.</t> Images show comparison between unamplified detection (fluorescent oligonucleotide complementary to conjugated oligonucleotide) versus PASTA amplification at increasing tyramine-oligonucleotide concentrations. In the PASTA workflow, antibody-bound oligonucleotides are recognized by complementary oligo-HRP conjugates, which catalyze the deposition of distinct tyramine-oligonucleotide barcodes. Right panels show quantification of log10(fold change) in signal intensity compared to background controls, demonstrating concentration-dependent signal enhancement. Scale bars: 100 µm. (C) Comparison of unamplified versus PASTA-amplified detection for clinically relevant markers (Fas Ligand, CD45RA, PD-L1, CD20, CD11c) on the same tissue section. Violin plots quantify the significant signal enhancement achieved with PASTA amplification for each marker. Scale bars: 100 µm. (D) High-magnification imaging demonstrating spatial resolution and multiplexing capabilities. Left panel: CD11c (yellow), CD3 (magenta), and CD20 (cyan) with mixed amplification (unamplified CD11c, 5 µM PASTA for CD3, 10 µM PASTA for CD20). Right panel: CD45RA (magenta), FasL (yellow), Iba-1 (cyan), and PD-L1 (not colored) with varied PASTA amplification concentrations. Scale bars: 500 µm (main images), 100 µm (insets).
    Ffpe Tissues, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ffpe tissues/product/AMS Biotechnology
    Average 94 stars, based on 1 article reviews
    ffpe tissues - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    human tonsil tissue slides  (AMS Biotechnology)
    96
    AMS Biotechnology human tonsil tissue slides
    (A) Overview schematic of the PASTA workflow. HRP recruitment including in situ hybridization, unconjugated antibodies, and proximity ligation assays enables tyramine radical formation. These radicals deposit oligos onto nearby proteins in the cells and tissues through covalent binding to tyrosine residues, creating stable protein-oligonucleotide conjugates that resist degradation and enable serial amplification. (B) Concentration-dependent signal amplification of CD3 and Iba1 in <t>FFPE</t> <t>tissues.</t> Images show comparison between unamplified detection (fluorescent oligonucleotide complementary to conjugated oligonucleotide) versus PASTA amplification at increasing tyramine-oligonucleotide concentrations. In the PASTA workflow, antibody-bound oligonucleotides are recognized by complementary oligo-HRP conjugates, which catalyze the deposition of distinct tyramine-oligonucleotide barcodes. Right panels show quantification of log10(fold change) in signal intensity compared to background controls, demonstrating concentration-dependent signal enhancement. Scale bars: 100 µm. (C) Comparison of unamplified versus PASTA-amplified detection for clinically relevant markers (Fas Ligand, CD45RA, PD-L1, CD20, CD11c) on the same tissue section. Violin plots quantify the significant signal enhancement achieved with PASTA amplification for each marker. Scale bars: 100 µm. (D) High-magnification imaging demonstrating spatial resolution and multiplexing capabilities. Left panel: CD11c (yellow), CD3 (magenta), and CD20 (cyan) with mixed amplification (unamplified CD11c, 5 µM PASTA for CD3, 10 µM PASTA for CD20). Right panel: CD45RA (magenta), FasL (yellow), Iba-1 (cyan), and PD-L1 (not colored) with varied PASTA amplification concentrations. Scale bars: 500 µm (main images), 100 µm (insets).
    Human Tonsil Tissue Slides, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human tonsil tissue slides/product/AMS Biotechnology
    Average 96 stars, based on 1 article reviews
    human tonsil tissue slides - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    human tonsil tissue slide  (AMS Biotechnology)
    96
    AMS Biotechnology human tonsil tissue slide
    (A) Overview schematic of the PASTA workflow. HRP recruitment including in situ hybridization, unconjugated antibodies, and proximity ligation assays enables tyramine radical formation. These radicals deposit oligos onto nearby proteins in the cells and tissues through covalent binding to tyrosine residues, creating stable protein-oligonucleotide conjugates that resist degradation and enable serial amplification. (B) Concentration-dependent signal amplification of CD3 and Iba1 in <t>FFPE</t> <t>tissues.</t> Images show comparison between unamplified detection (fluorescent oligonucleotide complementary to conjugated oligonucleotide) versus PASTA amplification at increasing tyramine-oligonucleotide concentrations. In the PASTA workflow, antibody-bound oligonucleotides are recognized by complementary oligo-HRP conjugates, which catalyze the deposition of distinct tyramine-oligonucleotide barcodes. Right panels show quantification of log10(fold change) in signal intensity compared to background controls, demonstrating concentration-dependent signal enhancement. Scale bars: 100 µm. (C) Comparison of unamplified versus PASTA-amplified detection for clinically relevant markers (Fas Ligand, CD45RA, PD-L1, CD20, CD11c) on the same tissue section. Violin plots quantify the significant signal enhancement achieved with PASTA amplification for each marker. Scale bars: 100 µm. (D) High-magnification imaging demonstrating spatial resolution and multiplexing capabilities. Left panel: CD11c (yellow), CD3 (magenta), and CD20 (cyan) with mixed amplification (unamplified CD11c, 5 µM PASTA for CD3, 10 µM PASTA for CD20). Right panel: CD45RA (magenta), FasL (yellow), Iba-1 (cyan), and PD-L1 (not colored) with varied PASTA amplification concentrations. Scale bars: 500 µm (main images), 100 µm (insets).
    Human Tonsil Tissue Slide, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human tonsil tissue slide/product/AMS Biotechnology
    Average 96 stars, based on 1 article reviews
    human tonsil tissue slide - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    ffpe human tonsil tissue blocks  (AMS Biotechnology)
    94
    AMS Biotechnology ffpe human tonsil tissue blocks
    (A) Overview schematic of the PASTA workflow. HRP recruitment including in situ hybridization, unconjugated antibodies, and proximity ligation assays enables tyramine radical formation. These radicals deposit oligos onto nearby proteins in the cells and tissues through covalent binding to tyrosine residues, creating stable protein-oligonucleotide conjugates that resist degradation and enable serial amplification. (B) Concentration-dependent signal amplification of CD3 and Iba1 in <t>FFPE</t> <t>tissues.</t> Images show comparison between unamplified detection (fluorescent oligonucleotide complementary to conjugated oligonucleotide) versus PASTA amplification at increasing tyramine-oligonucleotide concentrations. In the PASTA workflow, antibody-bound oligonucleotides are recognized by complementary oligo-HRP conjugates, which catalyze the deposition of distinct tyramine-oligonucleotide barcodes. Right panels show quantification of log10(fold change) in signal intensity compared to background controls, demonstrating concentration-dependent signal enhancement. Scale bars: 100 µm. (C) Comparison of unamplified versus PASTA-amplified detection for clinically relevant markers (Fas Ligand, CD45RA, PD-L1, CD20, CD11c) on the same tissue section. Violin plots quantify the significant signal enhancement achieved with PASTA amplification for each marker. Scale bars: 100 µm. (D) High-magnification imaging demonstrating spatial resolution and multiplexing capabilities. Left panel: CD11c (yellow), CD3 (magenta), and CD20 (cyan) with mixed amplification (unamplified CD11c, 5 µM PASTA for CD3, 10 µM PASTA for CD20). Right panel: CD45RA (magenta), FasL (yellow), Iba-1 (cyan), and PD-L1 (not colored) with varied PASTA amplification concentrations. Scale bars: 500 µm (main images), 100 µm (insets).
    Ffpe Human Tonsil Tissue Blocks, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ffpe human tonsil tissue blocks/product/AMS Biotechnology
    Average 94 stars, based on 1 article reviews
    ffpe human tonsil tissue blocks - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Overview schematic of the PASTA workflow. HRP recruitment including in situ hybridization, unconjugated antibodies, and proximity ligation assays enables tyramine radical formation. These radicals deposit oligos onto nearby proteins in the cells and tissues through covalent binding to tyrosine residues, creating stable protein-oligonucleotide conjugates that resist degradation and enable serial amplification. (B) Concentration-dependent signal amplification of CD3 and Iba1 in FFPE tissues. Images show comparison between unamplified detection (fluorescent oligonucleotide complementary to conjugated oligonucleotide) versus PASTA amplification at increasing tyramine-oligonucleotide concentrations. In the PASTA workflow, antibody-bound oligonucleotides are recognized by complementary oligo-HRP conjugates, which catalyze the deposition of distinct tyramine-oligonucleotide barcodes. Right panels show quantification of log10(fold change) in signal intensity compared to background controls, demonstrating concentration-dependent signal enhancement. Scale bars: 100 µm. (C) Comparison of unamplified versus PASTA-amplified detection for clinically relevant markers (Fas Ligand, CD45RA, PD-L1, CD20, CD11c) on the same tissue section. Violin plots quantify the significant signal enhancement achieved with PASTA amplification for each marker. Scale bars: 100 µm. (D) High-magnification imaging demonstrating spatial resolution and multiplexing capabilities. Left panel: CD11c (yellow), CD3 (magenta), and CD20 (cyan) with mixed amplification (unamplified CD11c, 5 µM PASTA for CD3, 10 µM PASTA for CD20). Right panel: CD45RA (magenta), FasL (yellow), Iba-1 (cyan), and PD-L1 (not colored) with varied PASTA amplification concentrations. Scale bars: 500 µm (main images), 100 µm (insets).

    Journal: bioRxiv

    Article Title: PASTA: Versatile Tyramine-oligonucleotide Amplification for Multi-modal Spatial Biology

    doi: 10.1101/2025.04.30.651463

    Figure Lengend Snippet: (A) Overview schematic of the PASTA workflow. HRP recruitment including in situ hybridization, unconjugated antibodies, and proximity ligation assays enables tyramine radical formation. These radicals deposit oligos onto nearby proteins in the cells and tissues through covalent binding to tyrosine residues, creating stable protein-oligonucleotide conjugates that resist degradation and enable serial amplification. (B) Concentration-dependent signal amplification of CD3 and Iba1 in FFPE tissues. Images show comparison between unamplified detection (fluorescent oligonucleotide complementary to conjugated oligonucleotide) versus PASTA amplification at increasing tyramine-oligonucleotide concentrations. In the PASTA workflow, antibody-bound oligonucleotides are recognized by complementary oligo-HRP conjugates, which catalyze the deposition of distinct tyramine-oligonucleotide barcodes. Right panels show quantification of log10(fold change) in signal intensity compared to background controls, demonstrating concentration-dependent signal enhancement. Scale bars: 100 µm. (C) Comparison of unamplified versus PASTA-amplified detection for clinically relevant markers (Fas Ligand, CD45RA, PD-L1, CD20, CD11c) on the same tissue section. Violin plots quantify the significant signal enhancement achieved with PASTA amplification for each marker. Scale bars: 100 µm. (D) High-magnification imaging demonstrating spatial resolution and multiplexing capabilities. Left panel: CD11c (yellow), CD3 (magenta), and CD20 (cyan) with mixed amplification (unamplified CD11c, 5 µM PASTA for CD3, 10 µM PASTA for CD20). Right panel: CD45RA (magenta), FasL (yellow), Iba-1 (cyan), and PD-L1 (not colored) with varied PASTA amplification concentrations. Scale bars: 500 µm (main images), 100 µm (insets).

    Article Snippet: The FFPE tissues used in this study were commercially available tonsil tissues (AMSBio, #AMS6022) for and and commercially available HeLa cell pellets (ACDBio, #310045) for .

    Techniques: In Situ Hybridization, Ligation, Binding Assay, Amplification, Concentration Assay, Comparison, Marker, Imaging, Multiplexing